Ivey Business School (Canada)
-
Impak Finance (B): Covid-19 and Its Effects on the Impact Economy
Diane-Laure Arjalies; Delphine Gibassier; Andrew NewtonCase IVEY-9B20M217-EStrategyIn case B, in late summer 2020, the founder has decided to prioritize the company's rating agency, advocating for robust and standardized impact assessments for all firms. He felt confident about his company's new strategic direction and focus during theStarting at €5.74
-
Verge Capital: Investing for Social Impact
Diane-Laure Arjalies; Sandy Chen; Sarangen Sathasivam; Andrew NewtonCase IVEY-9B20M135-EEntrepreneurship, StrategyVerge Capital was a social finance organization in London, Ontario, that connected local aspiring entrepreneurs with funds that would support initiatives with societal or environmental missions that benefited local communities. In 2019, the social finance manager at Verge Capital had to recommend one of two social impact business proposals that the organization should fund a CA$30,000 loan to. The two options were (1) Sri Lankan Foods, which oper...Starting at €8.20
-
The Heat is ON
Mark Zbaracki; Maziar RazCase IVEY-9B14M097-EEntrepreneurship, StrategyIn January 2014, the chief executive officer of AutoTherm, a small smart-thermostat design company located in Toronto, Canada, was considering the company’s future in light of the uncertainties and fast changing dynamics of the industry. As an incumbent and small engineering firm, AutoTherm’s plans to sell its first product, B133, through partnership with a large electronics company had not been quite successful. Given the dire state of the compa...Starting at €8.20
-
Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada
Mark Zbaracki; Jedy WangCase IVEY-9B16M138-EStrategyThe Canadian brand manager of Zelboraf had to decide how to introduce and price Zelboraf in the Canadian market. Zelboraf was a breakthrough discovery in treatment for melanoma cancer patients. Hoffmann-La Roche (Roche) began developing Zelboraf in 2005. During the clinical trials, the drug yielded such positive results in targeting late-stage (metastatic) melanoma cancer that Roche ended clinical trials early in order to expedite FDA approval an...Starting at €8.20
-
Impak Finance (A): Building the Impact Economy through Systems Change
Diane-Laure Arjalies; Delphine Gibassier; Andrew NewtonCase IVEY-9B20M216-EStrategyThe founder and chief executive officer of impak Finance Inc. had grown his financial technology start-up, based in Montreal, Canada, into a company with two main business lines: an extensive and comprehensive assessment and rating agency that used advancStarting at €8.20